Wi-Fi standards remain as confusing as ever.

Data from ongoing Phase 1 study of AX-0810 in healthy volunteers demonstrated dose-dependent target engagement on all key ...

Korean researchers have developed a technology that could simultaneously resolve the power consumption and data transmission ...

Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.

ProQR Therapeutics (PRQR) stock rises as the company posts early-stage trial data for AX-0810, an experimental therapy for liver diseases. Read more here.

Findings provide mechanistic support for previously reported clinical outcomes of clinical reversal of platinum resistance/refractoriness from ...

Cohere Technologies was awarded a $28 million contract by the Department of Defense (DoD) to develop radio access network (RAN) technologies to advance 5G/6G infrastructure. The contract will support ...

Epicrispr Biotechnologies, a clinical-stage company pioneering epigenetic therapies, today announced new interim data from its ongoing open-label Phase 1/2 first-in-human study of EPI-321 in ...

Optical interconnects, leveraging intrinsic advantages such as high bandwidth, low loss, and immunity to electromagnetic interference (EMI), are thus regarded as a promising solution to these barriers ...

Mwyngil Therapeutics, a biotech company focused on developing innovative small molecule therapeutics for cardiometabolic disease, today announced positive in vivo proof-of-concept results from its ...

Virginia officially introduced a new mechanism for managing high-risk traffic offenders, shifting the legal parameters for ...